Loading people...
Auriel August is a Principal at Santé Ventures based in Austin, Texas, where she specializes in early-stage healthcare, medical technology, and life sciences investments. Since joining the firm in the fourth quarter of 2021, she has led internal thematic research across heart failure interventions and cardiac monitoring while serving as a board observer for five of the firm's portfolio companies. Before entering venture capital, August completed her general surgery residency at Stanford University and served as a Stanford Biodesign Innovation Fellow. She previously worked as a Physician-In-Residence at IDEO, designing medical devices and digital health technologies, after earning her medical degree from Dartmouth College. Recognized as a Rising Star by Venture Capital Journal, her current focus remains on leveraging her clinical expertise to evaluate and cultivate emerging medical device manufacturers and digitally enabled healthcare services.
Auriel August serves as a Senior Associate at Santé Ventures, a distinguished venture capital firm renowned for its strategic investments in the healthcare and life sciences sectors. In this pivotal role, Auriel is deeply involved in the entire investment lifecycle, from initial market research and deal sourcing to due diligence and portfolio management. Her expertise is critical in identifying early-stage and growth-stage companies that are developing transformative technologies and services aimed at improving patient outcomes and healthcare efficiency.
Santé Ventures, underpins Auriel August's investment focus, which spans a broad spectrum of healthcare innovation. This includes cutting-edge biotechnology, advanced medical devices, disruptive digital health platforms, and innovative healthcare services. She is particularly adept at analyzing complex scientific and clinical data, assessing market potential, and evaluating the leadership teams behind promising ventures. Her work helps Santé Ventures maintain its position at the forefront of healthcare investment, backing companies that are poised to make a significant impact on the future of medicine.
Auriel's career background is built upon a strong foundation in both scientific understanding and financial acumen. Prior to her role at Santé Ventures, she likely honed her analytical skills in roles that provided exposure to healthcare innovation, perhaps in healthcare consulting, biomedical research, or a related financial advisory capacity. This diverse experience equips her with a unique perspective, enabling her to bridge the gap between scientific breakthroughs and viable commercial opportunities. Her commitment to understanding the intricate dynamics of the healthcare ecosystem makes her an invaluable asset to the Santé Ventures team and its portfolio companies.
While specific deal details are often proprietary, Auriel August contributes significantly to Santé Ventures' robust portfolio. She works closely with partners and other associates to identify and nurture companies that are poised for substantial growth and positive impact within their respective healthcare niches. Her contributions help shape the firm's investment strategy, ensuring that capital is deployed to ventures that align with Santé Ventures' mission to support innovation that truly matters in healthcare. Auriel's dedication to fostering groundbreaking solutions underscores her commitment to advancing medical technology and patient care.
Auriel August is a Senior Associate at Santé Ventures, a venture capital firm specializing in healthcare and life sciences investments. She is involved in identifying, evaluating, and executing investments in innovative healthcare companies.
Auriel August, through her role at Santé Ventures, invests in a wide range of healthcare and life sciences sectors. This includes biotechnology, medical devices, digital health, and healthcare services, focusing on early-stage and growth-stage companies.
Auriel August works as a Senior Associate at Santé Ventures, a prominent venture capital firm dedicated to investing in the healthcare and life sciences industries.
